Clinical trial
Etanercept With Tacrolimus for Psoriasis
NCT00134394 · University of Medicine and Dentistry of New Jersey, Other · Completed
Key facts
| NCT number | NCT00134394 |
|---|---|
| Title | Etanercept With Tacrolimus for Psoriasis |
| Official title | Double-Blind, Placebo-Controlled, Bilateral Comparison of Topical Tacrolimus 0.1% vs. Placebo Ointment as Adjunctive Therapy for Patients With Moderate to Severe Psoriasis Who Are Candidates for or Poor Responders to Etanercept Therapy |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Etanercept plus tacrolimus |
| Enrollment | 20 |
| Start date | Feb 1, 2005 |
| Completion | Dec 1, 2007 |
| First posted | Aug 24, 2005 |
| Last update posted | Aug 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: